12 participants
Phase I Study of [111In]-FPI-2107 in EGFR Mutation-positive NSCLC
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-17
- Start Date:
- 2026-02-27
- Completion:
- 2026-07-21
Conditions
- EGFR Mutation-positive NSCLC
Interventions
- DRUG
No Results Yet